Clinical Research Directory
Browse clinical research sites, groups, and studies.
Nanodropper Use in Primary Open-Angle Glaucoma Patients: A Non-Inferiority Trial
Sponsor: 59th Medical Wing
Summary
This randomized, single-masked, crossover, non-inferiority trial aims to evaluate the safety and efficacy of Nanodropper-mediated microdrops of ocular hypotensive topical treatments (experimental intervention) compared to standard drops of the same medication(s) (active comparator) in Wilford Hall Ambulatory Surgical Center (WHASC) primary open-angle glaucoma (POAG) and ocular hypertension (OHTN) patients.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
30
Start Date
2022-03-17
Completion Date
2024-03-17
Last Updated
2023-05-06
Healthy Volunteers
No
Interventions
Nanodropper
Nanodropper delivers 1/5 of eye drop volume compared to regular droppers
Regular dropper
Delivers full eye drop volume
Locations (1)
Wilford Hall Ambulatory Surgical Center
Lackland Air Force Base, Texas, United States